Search earnings tickers

REGN

2025Q1BMO

Regeneron Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2025-04-29 · Fiscal end 2025-03-31 · Features as of 2025-04-28

← Earnings history

Street

Consensus EPS8.48

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.4%

IV front—

P/C full—

P/C front—

Features as of2025-04-28

Run-up

Close—

Ret 5d+8.8%

Ret 10d+10.2%

Ret 20d-4.2%

Ret 30d-8.4%

Print

Actual EPS

8.22Miss

Estimated EPS8.48

Actual revenue

3.0B

Surprise %-3.1%

Beat / missMiss

Beat streak 40

Beat streak 80

Reaction

1-day stock reaction+1.3%

Implied vs actual

Implied 2.4%Actual 8.0%

Gap reaction-8.0%

Day result-6.9%

Next-day upYes

Realized / IV3.35×

Post tape

Post 5d-1.8%

Post 10d+0.9%

Post volume2.7M

Vol ×10d2.79×

Vol ×20d2.38×

Post range6.7%